首页> 外文期刊>Journal of the Chinese Medical Association: JCMA >Outcomes of 23-gauge transconjunctival sutureless vitrectomy for acute postoperative endophthalmitis
【24h】

Outcomes of 23-gauge transconjunctival sutureless vitrectomy for acute postoperative endophthalmitis

机译:23线经结膜无缝玻璃体切除术治疗急性术后眼内炎的结果

获取原文

摘要

Background: To report our 3-year experience of 23-gauge transconjunctival sutureless vitrectomy (TSV) for acute postoperative endophthalmitis at a tertiary referral center in southern Taiwan. Methods: This retrospective chart review study included 19 patients with acute postoperative endophthalmitis who underwent 23-gauge TSV from January 2011 to January 2015?at Kaohsiung Veterans General Hospital, Taiwan. Bacterial and fungal cultures from aqueous samples, vitreous samples, or both were performed. Results: Nineteen patients (12 male; 7 female) were included. The mean age was 72.4?±?8.29 years. Acute postoperative endophthalmitis was noted in 18 patients after cataract surgery and in 1 patient after 23-gauge vitrectomy for a rhegmatogenous retinal detachment. Upon presentation, visual acuity was less than hand movement for 80% of the patients. Chief complaints included blurred vision (19 patients, 100%), followed by pain (10 patients, 52.6%) and red eye (4 patients, 21%). All patients were administered an intravitreal injection (IVI) of antibiotics and 23-gauge TSV, and the average number of IVIs was 2.68?±?1.73 (1–9 IVIs). The interval between their initial eye symptoms and vitrectomy was 4.11?±?4.73 days (0–2 days), and the interval between diagnosis with endophthalmitis and a vitrectomy was 1.11?±?1.52 days (0–6 days). The final visual acuity was no light perception for 1 patient (5.3%), between 6/60 and 6/12 for 8 patients (42.1%), and 6/12 or better for 9 patients (47.4%). No retinal detachment or hypotony was noted postoperatively in any case. Conclusion: 23-gauge vitrectomy is safe and effective for the management of acute postoperative endophthalmitis. Early diagnosis and treatment with 23-gauge vitrectomy may provide a good visual outcome.
机译:背景:要报道我们在台湾南部的一个三级转诊中心进行23口经结膜无缝玻璃体玻璃体切割术(TSV)在急性术后眼内炎中的3年经验。方法:这项回顾性图表审查研究包括19例2011年1月至2015年1月在台湾高雄荣民总医院接受23线TSV的急性术后眼内炎患者。从含水样品,玻璃体样品或两者中进行细菌和真菌培养。结果:共纳入19例患者(男12例;女7例)。平均年龄为72.4±8.29岁。白内障手术后有18例患者发生急性眼内炎,而23口玻璃体切割术后有1例患者因眼源性视网膜脱离而发生急性眼内炎。呈现后,80%的患者的视力小于手部动作。主要主诉包括视力模糊(19例,100%),其次是疼痛(10例,52.6%)和红眼(4例,21%)。所有患者均接受玻璃体内注射抗生素(IVI)和23号TSV,平均IVI数为2.68±1.73(1–9 IVI)。他们最初的眼部症状与玻璃体切除术之间的间隔为4.11?±?4.73天(0–2天),而诊断为眼内炎与玻璃体切除术之间的间隔为1.11?±1.52天(0–6天)。最终视力为1名患者(5.3%)无光感,8名患者(62.1%)在6/60至6/12之间,9名患者(47.4%)在6/12或更高。在任何情况下,术后均未发现视网膜脱离或低渗。结论:23号玻璃体切除术治疗急性术后眼内炎安全,有效。 23规格玻璃体切除术的早期诊断和治疗可提供良好的视觉效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号